Virginia Retirement Systems Et Al Esperion Therapeutics, Inc. Transaction History

Virginia Retirement Systems Et Al

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$4.81 - $11.92 $234,727 - $581,696	-48,800 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$11.34 - $21.37 $553,392 - $1.04 Million	48,800 New	48,800 $588,000
Q3 2020 Nov 12, 2020	SELL	$31.18 - $52.71 $364,806 - $616,707	-11,700 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$30.04 - $51.31 $156,208 - $266,812	5,200 Added 80.0%	11,700 $600,000
Q1 2020 May 12, 2020	SELL	$27.44 - $73.84 $49,392 - $132,912	-1,800 Reduced 21.69%	6,500 $205,000
Q4 2019 Jan 27, 2020	SELL	$35.4 - $59.82 $152,220 - $257,226	-4,300 Reduced 34.13%	8,300 $495,000
Q3 2019 Oct 22, 2019	BUY	$34.47 - $47.53 $272,313 - $375,487	7,900 Added 168.09%	12,600 $462,000
Q2 2019 Jul 26, 2019	BUY	$40.1 - $52.33 $188,470 - $245,951	4,700 New	4,700 $219,000

206

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $149M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.